8.A.10 The Slow Voltage-gated K+ Channel Accessory Protein (MinK or KCNE) Family
The MinK family, also called the KCNE family, is a small family of K+-selective channel accessory proteins found only in animals. MinK proteins are associated with and essential for the activities of K+ channel proteins such as the KvLQT1 protein (TC #1.A.1.15.1; VIC superfamily) encoded by the human LQT1 gene. A VIC superfamily (TC #1.A.1) member and the KvLQT1/MinK assembly generate the slowly activating K+ channel IKs. Some of these channels respond to a change in voltage very slowly; the current may reach its steady state only after 50 seconds. The KCNQ1 channel is differentially regulated by KCNE1 and KCNE2 (Li et al. 2014). KCNE2 exhibits an array of functions in the heart, stomach, thyroid and choroid plexus. A variety of interconnected disease manifestations caused by KCNE2 disruption involve both excitable cells such as cardiomyocytes, and non-excitable, polarized epithelia (Abbott 2015).
All sequenced MinK members are from mammals and are very similar. There are at least two isoforms, one found in intestinal or kidney epithelia, the other in cardiac tissue. MinK proteins are small (about 130 amino acids) with a single N-terminal transmembrane α-helical spanner, approximately at residues 45-65. The N-termini are extracellular while the large C-terminal tails are in the cytoplasm. The extracellular domains are glycosylated, and the activities of the proteins are regulated by phosphorylation of the cytoplasmic domains. They probably form heterooligomeric complexes and thereby modulate channel activity. There is evidence that residues in the MinK polypeptide chain are in close proximity to TMS6 in the channel complex, but are outside of the permeation pathway (Tapper and George, 2001). They not only affect channel gating and ion conduction, they also are required for efficient trafficking and cell surface expression (Chandrasekhar et al., 2006). There are two MinK subunits (a dimer of β) per tetrameric channel complex (Morin and Kobertz, 2008).
KCNE genes (KCNE1-5) encode a family of subunits affecting channel activity. A novel gene, KCNE6, has been discovered (Kasuya et al. 2024). Lundquist et al. 2006 mapped transcription start sites, delineated 5' genomic structure, and characterized functional promoter elements for each gene. They also identified alternatively spliced transcripts for both KCNE1 and KCNE3, including a cardiac-specific KCNE1 transcript. Analysis of relative expression levels of KCNE1-5 in a panel of human tissues revealed distinct, but overlapping, expression patterns. The coexpression of multiple functionally distinct KCNE genes in some tissues inferred complex accessory subunit modification of potassium channels (Lundquist et al. 2006). The involvement of channel auxiliary subunits in channel regulation and cancer has been reviewed (Haworth and Brackenbury 2019).
KCNE2 (also known as MiRP1) is expressed in the heart, is associated with human cardiac arrhythmia, and modulates cardiac Kv α subunits, hERG and KCNQ1, in vitro. KCNE2 and KCNQ1 are also expressed in parietal cells, leading to the speculation that they form a native channel complex there. The murine kcne2 gene has been disrupted (Roepke et al., 2006). kcne2 (-/-) mice have a severe gastric phenotype with reduced parietal cell proton secretion, abnormal parietal cell morphology, achlorhydria, hypergastrinemia, and striking gastric glandular hyperplasia arising from an increase in the number of non-acid secretory cells. Thus, KCNE2 is essential for gastric acid secretion (Roepke et al., 2006). KCNE genes are expressed in the human heart with a relative abundance ranking of KCNE1 > KCNE4 > KCNE5 ~= KCNE3 >> KCNE2 (Lundquist et al. 2005). In situ hybridization revealed prominent expression of KCNE1 and KCNE3-5 in human atrial myocytes. In cardiomyopathic hearts, expression of KCNE1, KCNE3, KCNE4, and KCNQ1 was increased, while KCNE2 and KCNE5 exhibited reduced expression. In a cell line stably expressing KCNQ1 and KCNE1, transient expression of KCNE3, KCNE4, or KCNE5 altered I(Ks) current profiles. Even in the presence of additional KCNE1, KCNE4 and KCNE5 exert dominant effects on I(Ks). Although KCNE1 is the predominant KCNE family member expressed in the human heart, the abundance of other KCNE transcripts including potential KCNQ1 suppressors (KCNE4 and KCNE5) and their altered expression patterns in disease suggest that a balance of KCNE accessory subunits may be important for cardiac K(V) channel function (Lundquist et al. 2005).
N-Glycosylation of membrane proteins is critical for their proper folding, co-assembly and subsequent matriculation through the secretory pathway. Bas et al. (2011) examined the kinetics of N-glycan addition to type I transmembrane KCNE1 K+ channel β-subunits, where point mutations that prevent N-glycosylation at one consensus site give rise to disorders of the cardiac rhythm and congenital deafness. KCNE1 has two distinct N-glycosylation sites: a typical co-translational site and a consensus site ∼20 residues away that unexpectedly acquires N-glycans after protein synthesis (post-translational). Mutations that ablate the co-translational site concomitantly reduce glycosylation at the post-translational site, resulting in unglycosylated KCNE1 subunits that cannot reach the cell surface with their cognate K+ channel. This long range inhibition is highly specific for post-translational N-glycosylation because mutagenic conversion of the KCNE1 post-translational site into a co-translational site restores both monoglycosylation and anterograde trafficking (Bas et al., 2011).
Accessory β-subunits of the KCNE gene family modulate the function of various cation channel α-subunits by the formation of heteromultimers. Among the most dramatic changes of biophysical properties of a voltage-gated channel by KCNEs (TC# 8.A.10.1.1) are the effects of KCNE1 on KCNQ1 channels. KCNQ1 and KCNE1 form native I(Ks) channels. Strutz-Seebohm et al. (2011) characterized molecular determinants of the KCNE1 interaction with KCNQ1 channels. KCNE1 binds to the outer face of the KCNQ1 channel pore domain, modifies interactions between voltage sensor, S4-S5 linker and the pore domain, leading to structural modifications of the selectivity filter and voltage sensor domain. Molecular dynamics simulations suggest a stable interaction of the KCNE1 transmembrane α-helix with the pore domain S5/S6 and part of the voltage sensor domain S4 of KCNQ1 in a putative pre-open channel state. Formation of this state may induce slow activation gating, the pivotal characteristic of native cardiac I(Ks) channels.
Voltage-gated potassium (Kv) channels comprise pore-forming α-subunits and a multiplicity of regulatory proteins, including the cardiac-expressed and cardiac arrhythmia-linked transmembrane KCNE subunits. N-terminally extended (L) KCNE3 and KCNE4 isoforms regulate human cardiac Kv channel α-subunits (Abbott 2016). As for short isoforms, KCNE3S and KCNE4S, KCNE3L inhibits hERG; KCNE4L inhibits Kv1.1; neither form regulats the HCN1 pacemaker channel. Unlike KCNE4S, KCNE4L is a potent inhibitor of Kv4.2 and Kv4.3. Co-expression of cytosolic β-subunit KChIP2, which regulates Kv4 channels in cardiac myocytes, partially relieves Kv4.3 but not Kv4.2 inhibition. Inhibition of Kv4.2 and Kv4.3 by KCNE3L was weaker, and its inhibition of Kv4.2 was abolished by KChIP2. KCNE3L and KCNE4L also exhibited subunit-specific effects on Kv4 channel complex inactivation kinetics, voltage dependence and recovery. KCNE4L co- localized with Kv4.3 in human atrium (Abbott 2016).
In the heart, KCNE1 associates with the alpha-subunit KCNQ1 to generate the slowly activating, voltage-dependent potassium current (IKs) that controls the repolarization phase of cardiacaction potentials. By contrast, in epithelial cells from the colon, stomach, and kidney, KCNE3 coassembles with KCNQ1 to form K+ channels that are voltage-independent K+ channels in the physiological voltage range. They are important for controlling water and salt secretion and absorption (Barro-Soria et al. 2017). This difference between these two KCNE subunits is due to the fact that they affect different gating transitions (Barro-Soria et al. 2017).
KCNQ1 (Q1) is a voltage-gated potassium channel that is modulated by members of the KCNE family, the best-characterized being KCNE1 (E1) and KCNE3 (E3). The Q1/E1 complex generates a channel with delayed activation and increased conductance. This complex is expressed in cardiomyocytes where it provides the IKs current that is critical for the repolarization phase of the cardiac action potential. The Q1/E3 complex, on the other hand, is expressed in epithelial cells of the colon and stomach, where it serves as a constitutively active leak channel to help maintain water and ion homeostasis. Studies show the single transmembrane segments (TMS) present in both E1 and E3 are essential to their distinct functions. More specifically, residues FTL located near the middle of the E1 TMS are essential for the delayed activation of Q1, while the corresponding TVG sites in E3 are critical for constitutive activation of the channe (Law and Sanders 2019).
The voltage-gated KCNQ1 potassium channel is regulated by co-assembly with KCNE auxiliary subunits. KCNQ1-KCNE1 channels generate the slow delayed rectifier current, IKs, which contributes to the repolarization phase of the cardiac action potential. A three amino acid motif (F57-T58-L59, FTL) in KCNE1 is essential for the slow activation. Kuenze et al. 2020 developed structural models of the complex that suggested how KCNE1 controls KCNQ1 activation. The FTL motif binds at a cleft between the voltage-sensing and pore domains and appears to affect the channel gate via an allosteric mechanism. A common transmembrane-binding mode for different KCNEs was suggested, which illuminates how specific differences in the interaction of their triplet motifs may determine the differences in KCNQ1 functional modulation by KCNE1 versus KCNE3 (Kuenze et al. 2020).
The generalized transport reaction catalyzed by MinK in complexation with other channel proteins is:
K+ (in) → K+ (out)
References:
Slow voltage-dependent K+ channel auxiliary protein (β-subunit), MinK or K2NE1. KCNQ1-KCNE1 complexes may interact intermittently with the actin cytoskeleton via the C-terminal region (Mashanov et al., 2010; Coey et al., 2011). The transmembrane region and the C-terminal cytoplasmic domains that abuts the KCNE1 TMS both interact with and regulate the KCNQ1 channel (Lvov et al. 2010; Zheng et al. 2010). Mutations in KCNE1 can cause Meniere's disease (Doi et al. 2005). MinK-related peptides, MiRPs, confer changes in Kv channel conductance, gating kinetics and pharmacology, and are fundamental to recapitulation of the properties of some native currents. Inherited mutations in KCNE genes are associated with diseases of cardiac and skeletal muscle as well as the inner ear (McCrossan and Abbott 2004).
Mammals
MinK of Rattus norvegicus (130 aas; P15383)
Potassium voltage-gated channel Isk-related family member 1, of 129 aas and one TMS, KCNE1 (Sahu et al. 2015). Mutations can give rise to hearing disorders including chronic tinitus (Sand et al. 2010). KCNE proteins modulate both homomeric Kv.2.1 and heteromeric Kv2.1/Kv6.4 channels (David et al. 2015). Slow-activating channel complexes formed by KCNQ1 and KCNE1 are essential for human ventricular myocyte repolarization, while constitutively active KCNQ1-KCNE3 channels are important in the intestine. Inherited sequence variants in human KCNE1 and KCNE3 cause cardiac arrhythmias by different mechanisms (Abbott 2015). KCNE confers pH sensitivity to KCNQ1 (Heitzmann et al. 2007). State-dependent interactions between KCNE1 and KCNQ1 have been demonstrated (Westhoff et al. 2017). KCNE1 and KCNE3 exhibit similar functional properties (Law and Sanders 2019). The proximal C-terminal regions of KCNQ1 and KCNE1 participate in a physical and functional interaction during channel opening that is sensitive to perturbation (Chen et al. 2019).
Animals
KCNE1 of Homo sapiens
K+ voltage-gated channel subfamily E member 2 (KCNE2) or minimum K+ channel-related peptide (MinK; MiRP1) (β-subunit) [associates with KCNH2/ERG1 and KCNQ1/KVLQT1 (McCrossan et al. 2009), as well as KCNQ2 and KCNQ3] (Eldstrom and Fedida, 2011; Roepke et al., 2006). Regulated by PKCδ phosphorylation (O'Mahony et al., 2007). A mutation (hERG T473P) in the transmembrane non-pore region causes clinical manifestations of long QT syndrome (Liu et al. 2012). Exhibits an array of functions in the heart, stomach, thyroid and choroid plexus. A variety of interconnected disease manifestations caused by KCNE2 disruption involve both excitable cells such as cardiomyocytes, and non-excitable, polarized epithelia (Abbott 2015). It's secondary structure has been determined (Abbott et al. 2008). Deletion of the Kcne2 structural gene in mice and humans gives rise to impaired insulin secretion as well as type 2 diabetes mellitus (Lee et al. 2017). The KCNE2 beta subunit is required for normal lung function and resilience to ischemia and reperfusion injury (Zhou et al. 2019).
Mammals
KCNE2 of Mus musculus (123 aas; Q9D808)
KCNE3 (β-subunit) constitutively opens outwardly rectifying KCNQ1 (Kv7.1) K+ channels by abolishing their voltage-dependent gating. KCNQ1/KCNE3 heteromers are present in basolateral membranes of intestinal and tracheal epithelial cells where they may facilitate transepithelial Cl- secretion (Preston et al., 2010). Mutations cause Meniere's disease and tinnitus. KCNE3 regulates Kv4.2 in spiral gangion neurons (Wang et al. 2014) and other voltage-gated ion channels (Kroncke et al. 2016). KCNE3 induces the constitutive activation of KCNQ1 in a process involving interactions in both sides of the membrane (Kroncke et al. 2016). The human ortholog (KCNE3; Q9Y6H6) is 93% identical to the mouse protein. The TMS of KCNE3 is less flexible and more stable than its N- and C-termini in different membrane environments. The conformational flexibility of N- and C-termini varies across the lipid environment. The TMS of KCNE3 spans the membrane width, having residue A69 close to the center of the lipid bilayer, and residues S57 and S82 close to the lipid bilayer membrane surfaces (Asare et al. 2022). This mouse protein is 93% identical to the human ortholog (Q9Y6H6).
Mammals
KCNE3 of Mus musculus (103 aas; AAH04629)
Potassium voltage-gated channel subfamily E regulatory subunit 5, KCNE5 of 142 aas and 1 TMS. It is a potassium channel ancillary subunit of that is essential for the generation of some native K+ currents by virtue of the formation of heteromeric ion channel complexes with voltage-gated potassium (Kv) channel pore-forming alpha subunits. It functions as an inhibitory beta-subunit of the repolarizing cardiac potassium ion channel KCNQ1 (Angelo et al. 2002).
KCNE5 of Homo sapiens
KCNE3 or MinK-related peptide 2 of 103 aas with 1 C-terminal TMS. It modulates the gating kinetics and enhances stability of the channel complex. It assembles with KCNB1 and modulates its gating characteristics of the delayed rectifier voltage-dependent response (McCrossan et al. 2003). It can associate with KCNC4/Kv3.4 to form the subthreshold voltage-gated potassium channel in skeletal muscle and establish the resting membrane potential in muscle cells. Its association with KCNQ1/KCLQT1 may form the intestinal cAMP-stimulated potassium channel involved in chloride secretion that produces a current with nearly instantaneous activation with a linear current-voltage relationship (Schroeder et al. 2000). Campbell et al. 2022 provided guidelines for detailed structural studies of KCNE3 in a native membrane environment, comparing lipid bilayer results to the isotropic bicelle structure and to the KCNQ1-bound cryo-EM structure. It has been implicated in autism spectrum disease (Ben-Mahmoud et al. 2024).
KCNE3B auxilary protein of Homo sapiens
MinK-related peptide 3 (MiRK3) or KCNE4 (β-subunit). KCNE4 is a crucial host factor for Orf virus infection by mediating viral entry (Sun et al. 2024).
Mammals
MiRP3 or KCNE4 of Mus musculus (170 aas; Q9WTW3)